Official Publications China International Capital Corporation Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:09:05 15/05/2026 BST			5-day change	1st Jan Change
20.42 ^HKD	-3.04%		-6.07%	+4.34%

05-13	Nanjing Haijing Pharmaceutical Co., Ltd. agreed to acquire 21.25% stake in Shanghai Rendu Biotechnology Co., Ltd. from Ju Jinliang, Qiming Weichuang Venture Capital Management Company Limited, Runcong Enterprise Management Center (Limited Partnership), China International Capital Corporation Limited, Qiming Ventures Fund III, Changzhou Jinxin Venture Capital Co., Ltd. and Novel Praise Limited for approximately CNY 520 million.	CI
05-08	Baidu AI Chip Unit Starts Dual-Listing Push in Shanghai, Hong Kong	DJ